• Earlier this month, SES AI Corporation presented at CES 2026 in Las Vegas and the Gordon Research Conference on Electrochemistry in Ventura, highlighting its latest advances in AI-enhanced battery technology.
• By sharing its electrochemistry research and AI-driven materials work on such high-profile stages, SES AI is potentially reinforcing its positioning with both technology partners and prospective enterprise users of its Molecular Universe platform.
• Next, we’ll explore how SES AI’s high-profile CES and electrochemistry conference appearances may influence its broader investment narrative.

Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

SES AI Investment Narrative Recap

To own SES AI, you need to believe its AI driven battery and Molecular Universe platform can translate deep electrochemistry know-how into meaningful commercial contracts before cash burn and dilution concerns dominate. The CES 2026 and Gordon Research Conference appearances help validate the technology story, but they do not materially change the near term catalyst of converting trials into paying enterprise users, or the key risk that delayed adoption and concentrated OEM relationships could prolong losses.

The recent term sheet for a joint venture with Hisun New Energy Materials stands out alongside these conference showings, because it is tied directly to commercializing Molecular Universe discovered electrolytes into recurring materials revenue. If SES AI can move from presentations and lab milestones to signed, revenue producing supply agreements through this JV and similar partnerships, that would speak more clearly to investors about the platform’s real world traction than any single event on the conference circuit.

However, while the story around AI enhanced batteries is appealing, investors should be aware that customer concentration and slow enterprise adoption could still...

SES AI’s narrative projects $199.7 million in revenue and $19.9 million in earnings by 2028.

Uncover how SES AI's forecasts yield a $3.00 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Eleven fair value estimates from the Simply Wall St Community span from US$1.44 to US$78.38, showing how far apart individual views can be. Against that backdrop, the reliance on a few large OEM contracts and unproven broad enterprise uptake means you may want to compare several of these perspectives before forming your own view on SES AI’s potential performance.

Explore 11 other fair value estimates on SES AI - why the stock might be a potential multi-bagger!

Build Your Own SES AI Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your SES AI research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free SES AI research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate SES AI's overall financial health at a glance.

Looking For Alternative Opportunities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.